[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"paracentesis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:paracentesis":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100324660","medical-economic-evaluation-of-the-care-of-refractory-ascites-by-implantation-of-alfapump-device-in-cirrhotic-patients-100324660",false,"NCT03506893","Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients","ARIAPUMP","Inclusion Criteria:\n\n* Patient with refractory ascites who has had a minimum of 5 paracentesis in the last 3 months.\n* Patient with an estimated life expectancy of at least 6 months on the day of inclusion.\n* Patient with contraindication to the application of a TIPS or who has expressed a refusal of the procedure or a non-functional TIPS\n* Patient affiliated with or in receipt of social security\n* Informed and written consent signed by the patient.\n\nExclusion Criteria:\n\n* Local or systemic infection in the month preceding the procedure\n* Hepatocellular carcinoma with palliative care\n* MELD Score \\> 18\n* Child Pugh C Score \\> 10\n* Creatinine Clearance \\\u003C 50 ml\u002Fmn\n* Digestive hemorrhage or episode of hepatic encephalopathy within two weeks prior to device insertion\n* Contraindication to general anesthesia\n* Contraindication to implant surgery of the device:\n\n  * Obstructive urological impairment\n  * Partitioning of ascites\n  * Coagulopathy\n* Persons referred to in Articles L1121-5 to L1121-8 of the CSP (corresponding to all protected persons: pregnant woman, parturient, breastfeeding mother, person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure).\n* Patient currently participating in other clinical research or who participated in a clinical trial within one month prior to inclusion.","ALL","18 Years",{"count":19,"type":20},90,"ESTIMATED","INTERVENTIONAL",[23],"NA","The hypothesis is that the Alfapump® strategy would be more effective in terms of QALYs generated , and that the cost of Alfapump® device and its implantation will be totally or partially offset by the reduction in the number of evacuating parentheses performed and the reduction in the number of complications in patients with refractory ascites awaiting liver transplantation or not. On the other hand, given the difference in the clinical profiles of these two populations (whether or not they are awaiting transplantation), these two populations will be study separately\n\nEvaluation of the medical-economic impact at 1 year of the two therapeutic strategies: implantation of Alfapump® versus repeated evacuating paracentesis in cirrhotic patients with refractory ascites without scheduled liver transplantation.",[26,27,28],"Ascites","Paracentesis","Cirrhosis",[30,31],"refractory ascite","pump system","RECRUITING","2025-03-25",{"date":35,"type":36},"2025-03-30","ACTUAL",{"date":38,"type":36},"2018-07-17",{"date":40,"type":20},"2027-05-31",{"name":42,"class":43},"University Hospital, Grenoble","OTHER",10,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":16,"minAge":17,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":21,"phases":57,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":69},"100513359","augmented-reality-ultrasound-guidance-100513359","NCT05964439","Augmented Reality Ultrasound Guidance","HoloUS: Augmented Reality Visualization of Live Ultrasound Images Using HoloLens for Ultrasound-guided Procedures","HoloUS","Inclusion Criteria:\n\n* Employees of the institution over 18 years.\n* Volunteers participants who provide oral consent.\n* For expert group, participants who have been trained to perform and are comfortable with point-of-care ultrasound procedures (e.g., residents, fellows, attendings, vascular access PAs\u002FNPs).\n\nExclusion Criteria:\n\n* Any previous experience or training using the current version of the HoloUS app on the HoloLens.",true,"100 Years",{"count":56,"type":20},44,[23],"Many medical procedures are done with the aid of ultrasound imaging, but they remain difficult to learn and perform. This study will use augmented reality technology for making these procedures potentially more intuitive, easier, more precise, and safer.",[27],"2024-07-02",{"date":62,"type":36},"2024-07-03",{"date":64,"type":36},"2022-03-11",{"date":66,"type":20},"2024-12-31",{"name":68,"class":43},"Children's National Research Institute",1]